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Abstract
Background: Visual assessment of cerebrospinal fluid (CSF) for
xanthochromia (yellow color) is practiced by the majority of laboratories world
wide as a means of diagnosing intracranical bleeds.
Methods: Colorimetric and spectralphotometric analysis of CSF samples for
recognising the presence of bilirubin either in low concentrations or in the presence
of haemolysed blood.
Results: The experiments provide the physiological and colorimetric basis for
abandoning visual assessment of CSF for xanthochromia.
Conclusion: We strongly recommend relying on spectrophotometry as the
analytical method of choice.Page - 5 -
Article
Subarachnoid haemorrhage (SAH) is one of the most striking conditions in
medicine with potentially fatal outcome. The analysis cerebrospinal fluid
(CSF) is a crucial diagnostic tool. The sensitivity detecting a bleed by CT falls
from 95% on day one to <10% three weeks after the event [1], whilst the
sensitivity of CSF analysis remains close to 100% [2].
The presence of pigments in CSF alters its visual appearance.
Oxyhaemoglobin makes it appear red or orange, whilst bilirubin gives the
yellow coloration of true xanthochromia. Oxyhaemoglobin arises both from a
traumatic tap and a true SAH. Importantly the conversion of oxyhaemoglobin
to bilirubin can only happen in in vivo, allowing distinction between a true
intracranial bleed and one due to a traumatic tap. Here we provide
physiological evidence that the commonly practised [3,4] visual assessment of
CSF should be abandoned and replaced by spectrophotometry.
Methods
To simulate the conditions in which bilirubin may be observed, a set of
experiments were designed. Firstly, to reproduce contamination by
oxyhaemoglobin as it may occur with a traumatic tap, a series of tubes
containing doubling dilutions of haemolysed blood (series 'A' inset in Fig 1A)
into CSF containing the same amount of bilirubin was prepared. Secondly, to
determine the lowest concentration of bilirubin that could be confidently
detected, we prepared a series of tubes containing doubling dilutions of
bilirubin alone (series 'B' inset in Fig 1A).
All tubes were examined visually for xanthochromia, in normal daylight or cool
white fluorescent light, the typical viewing conditions, by 11 analysts,
comprising clinical scientists, biomedical scientists or clinical neurology staff
within the Department of Neuroimmunology at National Hospital for Neurology
and Neurosurgery. The tubes were presented in a random order and thePage - 6 -
analysts were naive to their actual concentrations.
Once the visual assessments were complete, all samples were scanned
between 350 and 740 nm using an Ultrospec 4300 pro (Amersham
Biosciences). The same analysts were then asked to indicate whether
bilirubin was present or absent in the scan. The proportions of subjects finding
a positive result by visual or spectroscopic assessment were compared using
a 
2 test.
Finally, the x-y chromaticity coordinates of the spectrophotometric scans were
calculated, according to the standard procedures of specification for visual
assessment established by the Commission Internationale de l’Eclairage
(CIE, the International Commission on Illumination). This involves multiplying
the spectral transmittances of the samples, converted from their optical
densities, by the spectral concentration of the radiant power of the source
illuminating them and then multiplying the product by each of the three color
matching functions, which define the CIE standard colorimetric observer [5].
The resulting x-y chromaticity coordinates of the samples can then be plotted
in the CIE 1931 chromaticity diagram for the standard 2° field of view (Fig 1 A
& B), and their dominant wavelengths, which correspond to hue, and
excitation purities, which correspond to saturation, can be geometrically
calculated (see explanations in the Table and Figure legends and values in
Table 1). The calculations were made for two CIE illumination or lighting
standards: “D65,” which equates to average daylight; and “A”, which is for
tungsten light.
Results
Samples in series ‘A’ , when calculated for viewing by standard illuminant
D65, varied in their dominant wavelength from 572 nm (which falls near the
hue category ‘pure yellow’ [6]) to 615 nm (red). They also varied in their
excitation purity from 97.9% (highly saturated) to 34.1% (moderately
saturated). In contrast, the samples in series ‘B’ all had the same dominant
wavelength, 572 nm (yellow) but differed in their excitation purity from 0.62Page - 7 -
(very desaturated) to 36.6% (Table 1). The optical density for bilirubin (450-
460 nm) ranged from 3.5 to 0.36 for samples A1 to A14 and from 3.2 to 0.002
for samples B1 to B8.
A significantly higher proportion of the analysts detected traces of bilirubin
spectrophotometrically than visually, both when the xanthochromic CSF
samples were contaminated by the presence of haemolysed blood (Series ‘A’)
and when they were desaturated (Series ‘B’). In Series ‘A’, visual detection
failed for CSF samples with dominant wavelengths greater than 574 nm
(samples A1 – A7), most of which fall considerably outside the color category
‘pure yellow’. In Series ‘B’, bilirubin could not be reliably detected in CSF
specimens with excitation purity levels below 2.4% (samples B5 – B8). In
contrast, in both Series ‘A’ and ‘B’, bilirubin could be reliably detected in all the
samples by examining the spectrophotometric scans.
This study confirms that spectrophotometry is superior to color vision
for analysing CSF samples for the presence of bilirubin [7]. Most critical CSF
samples are either contaminated by oxyhaemoglobin or have only low levels
of bilirubin. Under such conditions, detection of xanthochromia becomes
unreliable, especially when viewed under an incandescent lighting or a
tungsten desk lamp (corresponding to CIE standard illuminant A). Indeed, a
lower proportion of the assessors were able to detect xanthochromia for
samples 'B4' (7/11, 
2=4.88, p<0.05), 'B5' (3/11, 
2=9.21, p<0.01) and 'B6'
(0/11, 
2=6.47, p=0.01, see insets in Fig. 1B) under tungsten light than under
daylight conditions. Colorimetric analysis revealed that all of the samples now
fell completely outside the ‘pure yellow’ category. This condition represents a
'worst-case scenario', such as may be encountered during a night on-call.
Discussion
The implications of these findings can be judged from our previous analysis of
spectrophotometric scans of CSF samples, which did not appear yellow in
almost 80% of the cases routinely encountered at the National Hospital forPage - 8 -
Neurology and Neurosurgery [8].
About 80% of all CSF samples with significant amounts of bilirubin
appear rather 'reddish' than 'yellow' [8] but that 99.7% of over 3,500
laboratories participating in two recent American surveys [3,4] still assess
samples by color vision. The observations presented here provide a
physiological basis for abandoning the visual assessment of CSF for
xanthochromia.Page - 9 -
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Table legend
Table 1. Color specifications (CIE 1931 x-y chromaticity coordinates, dominant
wavelengths and excitation purities), calculated with respect to CIE illuminant D65, of
14 samples derived by double diluting haemolysed blood (Series ‘A’) and 8 samples
derived from a double dilution of xanthochromic CSF in H2O (Series ‘B'). The
dominant wavelengths [3] were geometrically derived by drawing lines from the
white-point (D65) through the x-y chromaticity coordinates of the samples to the
corresponding spectral wavelengths indicated on the outer boundary (spectral locus)
of the chromaticity diagram (Figure 1). The excitation purities [3] are the ratios of
distances in the chromaticity diagram, indicating how far the chromaticity points of
the samples are displaced from the white-point towards the spectral locus. Also
shown are the observed frequencies of assessors who correctly identified the
presence of bilirubin in the vision and spectrophotometry experiments and the results
of the ² analysis.Page - 11 -
Figure legend
Figure 1 (A). A section of the CIE 1931 chromaticity diagram (the full diagram is
shown in the lower left-hand corner) displaying the x-y chromaticity coordinates of 14
samples simulating a traumatic tap derived by double diluting haemolysed blood into
xanthochromic CSF sample B1 (Series ‘A’, circles) and 8 samples derived from a
double dilution of xanthochromic CSF in H2O (Series ‘B’, triangles). The coordinates
have been calculated with respect to CIE illuminant D65 (white cross). For
reference, the x-y chromaticity coordinates and wavelengths of the spectral colors
from 550 nm (‘yellowish green’) to 620 nm (‘red’) are also indicated. The dominant
wavelengths (turquoise lines) of samples 'B1-B8' and sample 'A1' are shown. The
region corresponding to the color category 'pure yellow', which ranges between 575
and 580 nm, is indicated in pale grey (see summary table in [4]). The photographic
insets show the Series ‘A’ and ‘B’ samples illuminated by cool white fluorescent light.
(B). The x-y chromaticity coordinates of the 22 samples from Series ‘A’ (circles) and
'B' (triangles) calculated for CIE illuminant A (white cross). The dominant
wavelengths (turquoise lines) of samples 'B1-B8' and sample 'A1' are shown. The
photographic inset shows Series ‘A’ and 'B' illuminated by a tungsten halogen














A1 0.3824, 0.3990 615 97.9 0.00 0.72 12.57 <0.001
A2 0.3828, 0.3993 607 91.2 0.00 0.72 12.57 <0.001
A3 0.3836, 0.4002 596 77.3 0.00 0.72 12.57 <0.001
A4 0.3847, 0.4011 586 64.3 0.00 0.72 12.57 <0.001
A5 0.3868, 0.4030 580 55.4 0.09 0.72 9.21 <0.01
A6 0.3903, 0.4058 576 48.0 0.18 0.90 11.73 <0.001
A7 0.3961, 0.4097 574 42.8 0.63 1.00 4.88 <0.05
A8 0.4052, 0.4138 573 39.5 1.00 1.00 -- N.S.
A9 0.4209, 0.4166 572 36.7 1.00 1.00 -- N.S.
A10 0.4478, 0.4142 572 36.0 1.00 1.00 -- N.S.
A11 0.4922, 0.4000 572 34.8 1.00 1.00 -- N.S.
A12 0.5619, 0.3709 572 34.6 1.00 1.00 -- N.S.
A13 0.6354, 0.3383 572 34.3 1.00 1.00 -- N.S.
A14 0.6769, 0.3180 572 34.1 1.00 1.00 -- N.S.
B1 0.3883, 0.4052 572 36.6 1.00 1.00 -- N.S.
B2 0.3615, 0.3702 572 18.2 1.00 1.00 -- N.S.
B3 0.3474, 0.3518 572 9.3 1.00 1.00 -- N.S.
B4 0.3403, 0.3425 572 4.8 0.90 1.00 -- N.S.
B5 0.3366, 0.3378 572 2.4 0.45 1.00 8.25 <0.01
B6 0.3348, 0.3354 572 1.66 0.00 1.00 22.0 <0.001
B7 0.3338, 0.3341 572 1.04 0.00 1.00 22.0 <0.001
B8 0.3334, 0.3336 572 0.62 0.00 1.00 22.0 <0.001Page - 13 -